Table of Contents
Historical Data, Premium Insights, Market Dynamic, Analysis and Projection, By Product, Analysis and Projection, By Application, Analysis and Projection, By End-Use, Analysis and Projection, By Regional Analysis, Competitive Landscape, Company Profiles, Market Revenue, Sale & Price Analysis
Related Topics
Lyme Disease Diagnostic Devices Market Size Lung Disease Therapeutics Market Size Liver Disease Therapeutics Market Size Kitchen Installation Services Market SizeGlobal Lyme Disease Testing Market Size to Exceed USD 23.32 Billion by 2033
According to a research report published by Spherical Insights & Consulting, The Global Lyme Disease Testing Market Size is Expected to Grow from USD 10.80 Billion in 2023 to USD 23.32 Billion by 2033, at a CAGR of 8.00% during the forecast period 2023-2033.
Browse 210 market data Tables and 45 Figures spread through 190 Pages and in-depth TOC on the Global Lyme Disease Testing Market Size, Share, and COVID-19 Impact Analysis, By Technology (IGRA Testing and Others), By Test (Serological Test [ELISA and Western Blot], Lymphocytic Transformation Test, Urine Antigen Testing, Immunofluorescent Staining, and Nucleic Acid Test), By End-Use (Hospitals, Diagnostic Laboratories, and Others), and By Region (North America, Europe, Asia-Pacific, Latin America, Middle East, and Africa), Analysis and Forecast 2023 – 2033
The lyme disease testing market is the global market that deals with the manufacture, production, and distribution of testing kits that are employed to identify Lyme disease, which is a bacterial infection caused by a tick called Borrelia burgdorferi. Furthermore, the global market for Lyme disease testing is fueled by increasing disease prevalence, heightened awareness, and improvements in diagnostic technology. Government programs for early detection, expanding healthcare infrastructure, and enhanced access to testing further stimulate demand. Furthermore, improvements in molecular and rapid technologies for testing, as well as rises in research expenditure, help drive market growth throughout the forecast period. However, the high testing costs, limited accuracy of current diagnostics, misdiagnosis issues, lack of awareness, inadequate healthcare access in rural areas, and stringent regulatory approval processes.
The IGRA segment accounted for the largest share in 2023 and is anticipated to grow at a significant CAGR during the forecast period.
On the basis of the technology, the global lyme disease testing market is divided into IGRA testing and others. Among these, the IGRA segment accounted for the largest share in 2023 and is anticipated to grow at a significant CAGR during the forecast period. The segmental growth is attributed to its high accuracy, reliability in detecting Lyme disease, and growing adoption over traditional tests. Advancements in immunological diagnostics increased Lyme disease prevalence, and rising demand for early and precise detection drive significant CAGR growth during the forecast period.
The serological test segment accounted for the greatest share in 2023 and is anticipated to grow at a substantial CAGR over the forecast period.
On the basis of the test, the global lyme disease testing market is divided into serological test, lymphocytic transformation test, urine antigen testing, immunofluorescent staining, and nucleic acid test. The serological test is divided into ELISA and western blot. Among these, the serological test segment accounted for the greatest share in 2023 and is anticipated to grow at a substantial CAGR over the forecast period. The segmental growth is attributed to its widespread use, cost-effectiveness, and reliability in detecting Lyme disease antibodies. Growing disease prevalence, advancements in ELISA and Western blot techniques, and increased awareness drive demand, ensuring substantial CAGR growth over the forecast period.
The hospitals segment accounted for the largest share in 2023 and is anticipated to grow at a remarkable CAGR during the forecast period.
On the basis of the end-use, the global lyme disease testing market is divided into hospitals, diagnostic laboratories, and others. Among these, the hospitals segment accounted for the largest share in 2023 and is anticipated to grow at a remarkable CAGR during the forecast period. The segmental growth is attributed to the availability of advanced diagnostic facilities, high patient influx for Lyme disease testing, and improved healthcare infrastructure. Growing awareness, government initiatives for early detection, and increasing adoption of advanced testing methods drive remarkable CAGR growth during the forecast period.
North America is projected to hold the largest share of the global lyme disease testing market over the forecast period.
North America is projected to hold the largest share of the global lyme disease testing market over the forecast period. This is due to the high disease prevalence, advanced healthcare infrastructure, and strong government support for early diagnosis. Increased research funding, widespread awareness programs, and the presence of key diagnostic companies further drive market growth, ensuring the region’s largest share over the forecast period.
Asia Pacific is expected to grow at the fastest CAGR growth of the global lyme disease testing market during the forecast period. This is due to the increasing awareness of Lyme disease, improving healthcare infrastructure, and rising investments in diagnostic technologies. Expanding access to advanced testing, government initiatives for infectious disease control, and growing research collaborations further drive market expansion, making the region a key growth hub during the forecast period.
Company Profiling
Major vendors in the global lyme disease testing market are DiaSorin S.p.A, BIOMÉRIEUX, Oxford Immunotec, Bio-Rad Laboratories, Inc., Thermo Fisher Scientific, Inc., T2 Biosystems, IGeneX, Gold Standard Diagnostics, ZEUS Scientific, Trinity Biotech, and others.
Key Target Audience
Recent Development
Market Segment
This study forecasts revenue at global, regional, and country levels from 2023 to 2033. Spherical Insights has segmented the global lyme disease testing market based on the below-mentioned segments:
Global Lyme Disease Testing Market, By Technology
Global Lyme Disease Testing Market, By Test
Global Lyme Disease Testing Market, By End-Use
Global Lyme Disease Testing Market, By Regional
May 2025 - The Global Sickle Cell Disease Diagnosis Market Size is Expected to Grow from USD 2.70 Billion in 2023 to USD 11.00 Billion by 2033, at a CAGR of 15.08% during the forecast period 2023-2033.
May 2025 - The Global Rare Disease Genetic Testing Market Size is Expected to Grow from USD 1012.90 Million in 2023 to USD 3788.00 Million by 2033, at a CAGR of 14.10% during the forecast period 2023-2033.
May 2025 - The Global Rare Dermatological Disease Treatment Market Size is Expected to Grow from USD 6.78 Billion in 2023 to USD 11.04 Billion by 2033, at a CAGR of 5.00% during the forecast period 2023-2033.
We have received your message and would like to thank you for writing to us. If your inquiry is urgent, please use the telephone number listed below to talk to one of our staff members. Otherwise, we will reply by email as soon as possible.
+1 303 800 4326 +91 9561448932 emailsales@sphericalinsights.com
